$DMAC @diamedica #DM199 #stroke phase 2 result is so compelling that big pharma $ABBV $PFE $RGEN $BMS $JNJ should consider partnership or buying this small biotech. #stroke is still one of the deadliest disease out there but with only one approved drug (TPA). 😞